The effect of beta-adrenergic blockade (propranolol) on the coagulability of the blood across the human heart.
D000991:Antithrombins / Q000032:analysis; D001777:Blood Coagulation / Q000187:drug effects*; D001779:Blood Coagulation Factors / Q000032:analysis*; D001780:Blood Coagulation Tests; D003331:Coronary Vessels; D005165:Factor V / Q000032:analysis; D005169:Factor VIII / Q000032:analysis; D005340:Fibrinogen / Q000032:analysis; D005342:Fibrinolysis / Q000187:drug effects; D006352:Heart Ventricles; D006461:Hemolysis / Q000187:drug effects; D006801:Humans; D011433:Propranolol / Q000494:pharmacology*; D011516:Prothrombin / Q000032:analysis; D011517:Prothrombin Time; D014680:Veins
D000991:Antithrombins; D001779:Blood Coagulation Factors; D005165:Factor V; D011516:Prothrombin; D005169:Factor VIII; D005340:Fibrinogen; D011433:Propranolol